Skip to main content

Table 1 Basic clinicopathological characteristics of the 2894 patients with pN3 stage GC

From: A novel pN3 gastric cancer staging system with superior prognostic utility based upon the examination of over 31 lymph nodes: a propensity score-matching analysis

Characteristic

All Patients (n = 2894)

n

%

Age

 ≤ 60

1009

34.9

 > 60

1885

65.1

Race

White

1659

57.3

Black/Others*

1235

42.7

Sex

  

Male

1661

57.4

Female

1233

42.6

Primary site

Upper

115

4.0

Middle

358

12.4

Lower

1081

37.4

Curvature

668

23.1

Overlapping lesion

398

13.8

Stomach, NOS

274

9.5

Grade

Well differentiated

18

0.6

Moderately differentiated

406

14.0

Poorly differentiated

2388

82.5

Undifferentiated

82

2.8

Size

 ≤ 6 cm

1511

52.2

 > 6 cm

1383

47.8

pT stage

pT1a

10

0.3

pT1b

59

2.0

pT2

152

4.3

pT3

1220

42.2

pT4a

1102

38.1

pT4b

351

12.1

pN stage

pN3a

1763

60.9

pN3b

1131

39.1

TNM stage

IIB

55

1.9

IIIA

118

4.1

IIIB

1447

50.0

IIIC

1274

44.0

Adjuvant therapy

Observation

954

33.0

ART

83

2.9

ACT

664

22.9

ACRT

1193

41.2

  1. n, number of patients; NOS, not otherwise specified; ART, adjuvant radiotherapy; ACT, adjuvant chemotherapy; ACRT, adjuvant chemoradiotherapy
  2. *Referring to American Indian/AK Native, Asian/Pacific Islander